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Case Studies in Environmental Medicine 
(CSEM): Stoddard Solvent Toxicity
Goals and Objectives
The goal of the CSEM is to increase the primary care provider’s knowledge 
of hazardous substances in the environment and to aid in the evaluation of 
potentially exposed patients.
After completion of this educational activity, the reader should be able 
to discuss the major exposure route for Stoddard solvent, describe two 
potential environmental and occupational sources of Stoddard solvent 
exposure, state two reasons why Stoddard solvent is a health hazard, 
describe three factors contributing to Stoddard solvent toxicity, identify 
evaluation and treatment protocols for persons exposed to Stoddard 
solvent, and list two sources of information on Stoddard solvent.
Accreditation
Continuing Medical Education (CME)
• AMA: The Centers for Disease Control and Prevention (CDC) is 
accredited by the Accreditation Council for Continuing Medical 
Education (ACCME) to provide continuing medical education for 
physicians. CDC designates this educational activity for a maximum of 
2.0 hours in category 1 credit toward the American Medical 
Association (AMA) Physician’s Recognition Award. Each physician 
should claim only those hours of credit that he/she actually spent in the 
educational activity.
• AAFP: This activity has been reviewed and is acceptable for 2.0 
prescribed hour by the American Academy of Family Physicians 
(AAFP).
• ACEP: This activity has been approved by the American College 
of Emergency Physicians (ACEP) for 2.0 hours per issue of ACEP 
category 1 credit.
• AO A: This issue has been approved by the American Osteopathic 
Association (AOA) for 2 credit hours of category 2-B credit.
Continuing Nursing Education (CNE)
This activity for 2.2 contact hours is provided by CDC, which is accredited 
as a provider of continuing education in nursing by the American Nurses 
Credentialing Center’s Commission on Accreditation.
Continuing Education Units (CEU)
CDC has been approved as an Authorized Provider of continuing education 
and training programs by the International Association for Continuing 
Education and Training and awards 0.2 continuing education units (CEUs).
Instructions
See page 4
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The questionnaire and posttest must be completed and returned electronically, 
by fax, or by mail for eligibility to receive continuing education credit.
Instructions for Completing CSEM Online
1. Read this CSEM, Stoddard Solvent Toxicity, all answers are in the text.
2. Link to the online learner support system, CDC/ATSDR Training and Continuing Education Online, at http:// 
www.phppo.cdc.gov/phtnonline.
3. Once you access the PHTN online system, create a participant profile and login to the system.
4. Search the catalog and find this course, Case Studies in Environmental Medicine: Stoddard Solvent 
Toxicity.
5. Follow instructions to select the type of continuing education credit you want and register for the course.
6. Complete the course evaluation and posttest no later than September 29,2003.
7. If you score 70% or better on the posttest, you will be able to immediately print your continuing education certificate 
from your personal transcript.
Note: Even if you are not interested in receiving continuing education credit, please complete the course evaluation. 
To only evaluate the course, select “0 Audit” when presented with the credit selection list. We appreciate your input.
Instructions for Completing CSEM on Paper
1. Read this CSEM, Stoddard Solvent Toxicity, all answers are in the text.
2. Complete the evaluation questionnaire and posttest, including your name, mailing address, phone number, and 
e-mail address, if available.
3. Circle your answers to the questions. To receive your continuing education credit, you must answer all of the 
questions.
4. Sign and date the posttest.
5. Return the evaluation questionnaire and posttest, no later than September 1,2003, to CDC by one of the following 
methods:
Mail or Fax
Continuing Education Coordinator 404-498-0061
Division of Health Education and ATTN: Continuing Education Coordinator
Promotion, ATSDR 
MS E-33,1600 Clifton Road, NE 
Atlanta, GA 30333
6. If you score 70% or better on the posttest, you will receive an award certificate within 90 days of submitting your 
credit forms. This continuing education activity is free of charge.
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Case Study
A 50-year-old Air Force major is referred to your office. He is concerned 
about a recent episode in which he felt dizzy and lightheaded, and had 
chest discomfort. The tightness on the left side of his chest lasted about 
10 minutes. It did not radiate, and it was associated with some shortness of 
breath, but no diaphoresis. The patient is very concerned about possible 
cardiac illness because his brother died of a heart attack at the age of 54.
The episode described by the patient occurred during the previous 
weekend while he was alone in the vehicle maintenance shop working on his 
car. He denies any particularly strenuous activity and states that he simply 
changed the oil, cleaned the engine, and replaced some spark plugs.
Because it was cold outside, he had the garage doors closed and the 
building exhaust system off. He did not run the vehicle for prolonged periods 
of time. He did no welding, but he used a degreasing solution several times 
to remove grease from his hands. He also used the degreasing solution to 
clean the engine. After he sprayed the solution over the engine, he started 
the engine briefly The fumes burned his eyes, nose, and throat. He felt ill 
shortly thereafter, with the dizziness and light-headed feeling occurring just 
before the onset of chest discomfort. He has not had any similar episodes in 
the past.
The patient’s last physical examination was about 1 year ago. At that time, 
his cholesterol level was within normal limits, but his blood sugar was mildly 
elevated. After he lost 15 pounds, his glucose level returned to normal. He 
quit smoking 5 years ago and is taking no medications. He drinks about a 
six-pack of beer a week. His major exercise is walking 2 to 3 miles with his 
wife, three times a week, and occasionally bicycle riding with his sons. His 
parents are in their 70s; his mother has diabetes, and his father has 
hypertension and angina. The patient is a supervisor in the vehicle 
maintenance shop at the Air Force base, where he oversees staff in 
inventory and shop repair. During working hours, he spends little time in the 
vehicle maintenance areas. His hobbies include fishing and home renovation. 
He lives in Air Force housing with his wife and two children; his younger son 
has asthma.
The physical examination is unremarkable, except for crusting and scaling of 
the skin on the volar surface of the hands and wrists, which the patient has 
experienced several times over the last 2 years. Results of routine laboratory 
screening and a 12-lead electrocardiogram (ECG) are within normal limits.
The most significant exposures to Stoddard solvent occur in the workplace. 
The National Institute for Occupational Safety and Health (NIOSH) 
estimates that about 2 million U.S. workers (excluding military personnel)
A50-year-old man has dizziness, 
euphoria, and chest discomfort
Pretest
(a) What conditions would you 
consider in this patient’s 
differential diagnosis?
(b) What additional information 
would you seek during this 
visit?
(c) How will you evaluate this 
patient and manage the case?
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♦ Workers in industries that 
produce, use, or dispose of 
Stoddard solvent are at the 
greatest risk of exposure.
♦ The general population can be 
exposed to Stoddard solvent 
through contact with consumer 
cleaning agents, paint products, 
or dry-cleaned fabrics.
♦ Although Stoddard solvent may 
contaminate the environment 
via air, water, or soil, no human 
health effects from chronic 
exposure to low environmental 
levels have been reported.
were potentially exposed to Stoddard solvent from 1981 to 1983. Today, 
Stoddard solvent is used primarily by workers in the manufacturing industry 
(for degreasing), paint industry, and printing industries. Exposure to 
Stoddard solvent is of greatest concern when it is used without skin or 
respiratory protection and in poorly ventilated areas.
The odor threshold for Stoddard solvent is less than 1 part per million 
(ppm). However, after about 6 minutes, the olfactory sense fatigues, and 
Stoddard solvent is no longer detected by smell. Thus, odor is not a reliable 
indicator of exposure and may not provide adequate warning of dangerously 
high concentrations. Olfactory detection of Stoddard solvent returns after 
breathing fresh air for about 10 minutes.
Populations susceptible to Stoddard solvent toxicity include persons who 
are overexposed (because of inadequate ventilation or lack of skin or 
respiratory protection), persons with concurrent exposures to solvents that 
are similarly metabolized, or persons with a lowered threshold for toxicity. 
Stoddard solvent is probably metabolized in the liver; thus, preexisting liver 
disease (e.g., hepatitis or cirrhosis) would likely decrease the rate of 
metabolism and increase the amount of Stoddard solvent circulating in the 
blood. Because excretion probably occurs through the lungs and kidneys, 
persons with lung impairment (e.g., chronic obstructive pulmonary disease 
[COPD]) or renal insufficiency may retain Stoddard solvent or its 
metabolites, leading to an increased risk of toxicity.
Challenge
The patient brings you a Material Safety Data Sheet (MSDS) fo r  the 
degreasing solution he used on his car. The MSDS identifies the 
degreaser as Stoddard solvent. The patient also tells you that he has 
brought the solution home. He stores it in a gallon jug  in the basement 
and uses it occasionally to help his children clean their bicycles.
(1) The patient asks you whether these exposures to Stoddard solvent 
could be harmful to his children. What will you tell him?
“Stoddard solvent” is the name adopted by the National Association of 
Dryers and Cleaners to honor W. J. Stoddard for his work with petroleum 
distillates used in the dry-cleaning industry. Stoddard solvent is a distillation 
fraction of crude petroleum (distilling between about 300°F [149°C] and 
400°F [204°C]) that contains at least 200 products, predominantly C7 
through Cn hydrocarbons. The mixture typically consists of 30 to 50% 
straight-chain andbranched-chain alkanes (paraffins), 30 to 40% 
cycloalkanes (naphthenes), and 10 to 20% aromatic hydrocarbons.
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(Benzene, toluene, and xylene each represent less than 1% of the total 
mixture [Figure 1].) Although the toxicity of Stoddard solvent is not 
attributable to any one type of constituent, the aromatic components are 
considered to be more toxic than the paraffin or naphthene components.
Stoddard solvent is a colorless, flammable liquid that is insoluble in water.
It is volatile and has an odor similar to that of kerosene or gasoline. This 
description applies to a variety of other petroleum distillates including white 
spirits and mineral spirits, which are similar mixtures containing the same 
types of components as Stoddard solvent. However, the boiling ranges 
and ratios of hydrocarbon components of these three petroleum distillate 
fractions differ. Trade names for Stoddard solvent include Texsolve S 
and Varsol.
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Figure 1. Structure of Major Components of Stoddard Solvent
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Stoddard solvent is a multipurpose solvent used in industry primarily as a 
dry-cleaning solvent and a metal degreaser. Stoddard solvent is also used 
industrially as a thinning agent for paints, coatings, and waxes, and as a 
solvent for printing inks, photocopier toners, adhesives, rubber products, 
waxes, polishes, and pesticides.
Consumers may be exposed to Stoddard solvent through inhalation or 
dermal contact with cleaning products, paints, paint thinners, furniture 
refinishers, or pesticides. Stoddard solvent can also contaminate water and 
soil through industrial, consumer, or hazardous waste landfill discharges. 
Although the paraffin components of Stoddard solvent have low water 
solubility, they can adsorb to particles, and small amounts of these 
components may be ingested with suspended particulates in contaminated 
drinking water. The aromatic components of Stoddard solvent are generally 
more water soluble and may reach the groundwater. Both aliphatic and 
aromatic components rapidly undergo biodégradation by soil 
microorganisms, although total degradation may take years.
Biologic Fate
Data on the toxicokinetics and pathophysiology of Stoddard solvent are 
limited and largely extrapolated from what is known about the fate and 
effects of other related petroleum products such as white spirits. Inhalation is 
the principal route of significant exposure for most petroleum distillates. 
Dermal absorption is usually limited because petroleum distillates evaporate 
readily; however, dermal absorption is enhanced through nonintact skin or 
through prolonged contact with the liquid, although no systemic effects have 
been noted.
The main hazard from ingestion of paraffin-type petroleum products is 
pulmonary aspiration. Systemic toxicity is uncommon unless large volumes 
are ingested and absorbed. In one study of human volunteers exposed to 
white spirits via inhalation, the solvent was distributed by the blood to 
adipose tissue, with an average elimination half-life from adipose tissue of 
about 48 hours. Because neurologic effects are seen after exposure to white 
spirits, the solvent is probably distributed to the brain as well, although this 
has not been documented. The sites of metabolism and excretion for 
Stoddard solvent have not been identified. Given the composition of 
Stoddard solvent and its similarity to other refined petroleum solvents, some 
metabolism of Stoddard solvent likely occurs in the liver, and excretion 
occurs partially through the respiratory tract and kidneys.
Stoddard Solvent Toxicity
Physiologic Effects
Acute Exposure
Few studies of Stoddard solvent exposure have been done in humans. In 
addition, the existing data can be difficult to interpret because workers in 
most of the studies were exposed to mixtures of solvents. Acute exposure to 
Stoddard solvent at air concentrations below the odor threshold produces 
no adverse health effects. Studies in both experimental animals and humans 
indicate that exposure to high levels of Stoddard solvent can produce 
irritation of the skin, respiratory tract, and other mucous membranes and can 
generally cause transient neurologic effects. Some reports indicate that 
exposure of hydrocarbons may cause arrhythmias, myocardial depression, 
or even ventricular fibrillation.
Although case reports have been published of persons who were exposed 
to Stoddard solvent and subsequently suffered liver, kidney, or hematologic 
injury, a causal relationship has not been firmly established. Data from 
studies in humans and experimental animals provide inconsistent and 
inconclusive evidence of injury to these target organs.
Central Nervous System (CNS) Effects
The major effect associated with inhalation of paraffin-like solvents is CNS 
excitation, followed rapidly by CNS depression. In volunteers exposed to 
100 ppm of white spirits over 6 hours, no subjective CNS symptoms were 
detected; however, acute exposure to 700 ppm produced prolonged 
reaction times. Workers exposed chronically to unknown concentrations of 
Stoddard solvent reported a variety of neurologic complaints including 
headaches, fatigue, memory deficits, inebriation, and subtle changes in color 
vision (dyschromatopsia). Most of these findings were reversible upon 
discontinuation of exposure. In experimental animal studies, inhalation 
exposures to high levels of Stoddard solvent produced incoordination, 
tremors, clonic spasms, and death.
Cardiovascular Effects
A case report described a severe myocardial depression 72 hours after 
ingesting paint thinner. Inhalation of hydrocarbons may cause arrhythmias, 
possibly from sensitization of the myocardium to circulating catecholamines. 
In another report, an adult woman developed ventricular fibrillation and 
cardiopulmonary arrest after prolonged exposure to concentrated vapors 
from mineral spirits.
Respiratory Effects
Acute exposure to high concentrations of Stoddard solvent can irritate 
mucous membranes and cause upper respiratory tract irritation. The only 
available human study of respiratory effects from chronic exposure involves
Acute exposure to Stoddard 
solvent can cause respiratory 
tract irritation and neurologic 
effects.
Exposure to high levels of 
Stoddard solvent can result in 
CNS depression.
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♦ Inhalation of high 
concentrations of Stoddard 
solvent causes upper 
respiratory-tract irritation.
♦ Ingestion and attendant 
aspiration of hydrocarbon 
mixtures similar to Stoddard 
solvent have resulted in 
chemical pneumonitis.
♦ Stoddard solvent is a moderate 
skin irritant.
♦ Carcinogenicity of Stoddard 
solvent has not been evaluated 
by the International Agency for 
Research on Cancer (IARC).
♦ Stoddard solvent is not 
generally regarded as a human 
carcinogen.
♦ Evidence regarding 
reproductive effects of 
Stoddard solvent exposure in 
humans is inconclusive.
house painters who were exposed to paints containing Stoddard solvent for 
periods ranging from 4 to 42 years. These workers had no decrease in lung 
vital capacity or expiratory volume compared to workers in other industries. 
Exposure concentrations were not recorded.
Acute ingestion and attendant aspiration of hydrocarbon mixtures similar to 
Stoddard solvent have resulted in chemical pneumonitis that mimics adult 
respiratory distress syndrome. Typically, respiratory involvement progresses 
during the first day, with resolution during the second through fifth days after 
exposure ceases. Complications of severe overexposure by the aspiration 
route may also include pulmonaiy edema, pulmonary emphysema, 
pneumothorax, pleuritis, pleural effusion, empyema, and pneumatoceles.
Dermal Effects
Stoddard solvent is a skin irritant, producing dermatitis, ulcerated and 
vesicular lesions, and desquamation on prolonged contact with the liquid. 
Dermal injury is reversible if contact with the solvent ceases. The dermal 
effects appear to be secondary to Stoddard solvent’s ability to remove oils 
from the skin (defatting action). Stoddard solvent is associated with irritant 
contact dermatitis, and not with allergic contact dermatitis.
Carcinogenic Effects
Data from studies of Stoddard solvent exposure in experimental animals 
(dermal exposure) and in humans (inhalation exposure) have not 
conclusively demonstrated that Stoddard solvent is carcinogenic. 
Epidemiologic studies of painters and dry-cleaning workers exposed to 
mixed petroleum products have not consistently found elevated cancer risks, 
although some of these studies have noted increased incidences of 
respiratory tract, bladder, and kidney cancer. IARC has not classified 
Stoddard solvent carcinogenicity.
Stoddard solvent was not mutagenic in the Ames test, bacterial assays, 
mouse bone marrow studies, or in studies of human lymphocytes in vitro.
Reproductive and Developmental Effects
Existing data on the reproductive effects of Stoddard solvent are sparse. 
One study of male workers exposed chronically to mixed petroleum 
solvents indicated no sperm abnormalities. Because Stoddard solvent is fat 
soluble, it can probably cross the placenta and enter breast milk; however, 
this phenomenon has not been documented. Inhaled Stoddard solvent was 
not fetotoxic in experimental animals. The effects of Stoddard solvent on 
other reproductive endpoints in experimental animals have not been studied.
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Challenge
(2) Are the complaints o f the patient in the case study consistent with 
exposure to Stoddard solvent?
(3) Could the patient’s skin lesions have been caused by exposure to 
Stoddard solvent? I f  so, what actions would you advise?
Clinical Evaluation
History and Physical Examination
Exposure to Stoddard solvent produces clinical signs and symptoms similar to 
those caused by other aliphatic solvents. Medical evaluation of a patient with 
Stoddard solvent exposure should initially consist of a complete history and 
physical examination. The medical history should include the following:
• Temporal associations between exposure and health effects
• Occupational and environmental history of the patient and relevant 
household members
• Hobbies or household projects; solvent use in such activities as 
painting, paint removal, refinishing, and automotive repair
• Residence or worksite proximity to industries and hazardous waste 
sites
• Dose estimates, taking into account the amount of solvent used, routes 
of exposure, duration of exposure, and personal protection such as 
gloves and respiratory apparatus
• Accentuators of effects such as social habits (e.g., cigarette smoking; 
drug or ethanol use), intercurrent diseases, and other exposures.
Persons also exposed to other CNS depressants, such as solvent 
“huffing” or inhalant abuse, might be at increased risk.
(See Case Studies in Environmental Medicine: Taking an Exposure 
History.)
The physical examination should include evaluation of the skin, eyes, 
and mucous membranes for signs of irritation, and the CNS for signs of 
excitation or depression. Other organ systems that should be evaluated 
include the ophthalmologic (e.g., color vision testing), hematologic, 
hepatic, renal, and respiratory systems.
Signs and Symptoms
Acute Exposure
After aspiration of even small amounts, pulmonary aspiration of Stoddard 
solvent may result in serious chemical pneumonitis and pulmonary edema. 
Because of its aspiration hazard, Stoddard solvent is in Class 3 (may cause
11
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♦ The most serious effects of 
acute exposure to Stoddard 
solvent involve the CNS and 
the respiratory tract.
♦ Neurologic effects associated 
with chronic workplace 
exposure are generally 
reversible.
♦ There are no biomarkers for 
exposure to Stoddard solvent.
♦ Medical surveillance for 
workers exposed to Stoddard 
solvent should include a 
complete blood count, 
urinalysis, and tests to evaluate 
liver, kidney, and CNS 
functions.
irreversible effects that can be life-threatening). Reported symptoms of 
acute exposure to Stoddard solvent include lightheadedness, dizziness, 
visual disturbances, and drowsiness. Although Stoddard solvent has not 
been reported to cause respiratory depression or coma, it is chemically 
similar to other agents that can produce such effects with prolonged 
high-level exposure, such as gasoline. Irritation of the respiratory tract, 
mucous membranes, and skin can occur.
Chronic Exposure
Chronic exposure to Stoddard solvent has been associated with headaches, 
fatigue, intermittent episodes of inebriation, and memory deficits that 
generally resolve upon discontinuation of exposure. High-dose, chronic 
exposures to other volatile hydrocarbons, mainly through deliberate inhalant 
abuse, have been associated with memory, cognitive, and emotional 
disturbances.
Laboratory Tests
Direct Biologic Indicators
Because Stoddard solvent contains hydrocarbons of varying concentrations 
and volatility, and because formulations may vary, no specific hydrocarbon 
in the plasma or tissues is a reproducible index of exposure.
Indirect Biologic Indicators
Depending on route, exposure to Stoddard solvent has been associated with 
neuropsychiatric disorders, hepatotoxicity, kidney damage, and changes in 
blood-forming capacity. NIOSH has recommended that preplacement and 
medical surveillance examinations for workers exposed to refined petroleum 
products include a complete blood count and a urinalysis, and appropriate 
tests for function of the liver, nervous system, and kidneys. If 
neurobehavioral abnormalities are suspected, consider referring the patient 
for neuropsychologic tests that evaluate cognitive and emotional functioning.
Challenge
You have educated your patient about the health effects o f Stoddard 
solvent. A short time later, your patient calls to say that a neighbor 
who races cars and uses the vehicle maintenance shop on a regular 
basis is complaining o f chronic fatigue, headaches, and recent memory 
impairment.
(4) Your patient asks you i f  there is a test to determine whether his 
neighbor s condition might be due to Stoddard solvent. What is 
your answer?
(5) What would you recommend fo r  the neighbor?
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Treatment and Management
Acute Exposure
In cases of acute inhalation exposure to Stoddard solvent, the person should ♦ 
be removed immediately from the source of exposure. After initial evaluation 
and treatment to maintain respiratory and cardiovascular functions, 
decontamination procedures should be instituted. Remove contaminated 
clothing and wash exposed areas with mild soap and shampoo, then rinse 
thoroughly with water. Direct eye splashes should be treated by irrigation 
with saline or water for 15 minutes or until pain resolves.
Inhalation exposure may cause respiratory, circulatory, or mental status 
changes. Supplemental oxygen should be administered as needed. Further 
evaluation, including blood gas analyses, chest radiography, ECG 
monitoring, and baseline liver and kidney function tests, should be 
considered in serious overexposures.
Because the threat of systemic toxicity is low after Stoddard solvent 
ingestion and because of potential for pulmonary aspiration, gastric 
decontamination (i.e., emesis, lavage, cathartic, activated charcoal) is not 
recommended in most cases. Corticosteroids and prophylactic antibiotics 
are not necessary to treat persons with Stoddard solvent ingestion and 
pulmonary aspiration. An initial chest radiograph should be obtained to 
determine baseline, and the patient should be observed for 6 hours. Patients 
who are asymptomatic after 6 hours of observation may be discharged from 
the hospital. Patients who develop chemical pneumonitis will require 
intensive supportive pulmonary care.
Acute eczematous contact dermatitis due to contact with liquid Stoddard 
solvent can be treated with traditional measures. Monitor for secondary 
infection, and treat with topical or systemic antibiotics as needed.
Chronic Exposure
Whether systemic health effects occur from low-level, chronic exposures to 
Stoddard solvent is uncertain. If symptoms persist, investigate other sources 
of exposure to Stoddard solvent or similar agents, and other etiologies. In 
cases of persistent neurologic symptoms, formal neuropsychologic testing 
may be useful for diagnostic purposes and to establish baseline functioning.
Challenge
(6) How will you treat the patient and manage the case?
There are no known antidotes 
for Stoddard solvent toxicity. 
Treatment consists of 
supportive measures and 
prevention of further 
overexposure.
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Standards and Regulations
Workplace
The Occupational Safety and Health Administration has established a time-weighted average (TWA) standard of 
500 ppm (2,900 milligrams per cubic meter of air [mg/m3]) for an 8-hour workday, 40-hour workweek to prevent 
nervous system and skin damage. NIOSH has published a recommended exposure limit o f350 mg/m3 TWA for a 
10-hour workday and a ceiling level of 1,800 mg/m3 (15-minute sampling period). The American Conference of 
Governmental Industrial Hygienists has recommended a threshold limit value TWA of 100 ppm (525 mg/m3) for an 
8-hour workshift
Environment
EPA has no current standards for Stoddard solvent in air or water.
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Answers to Pretest and Challenge Questions
Pretest
(a) The differential diagnosis for this patient might include coronary artery disease, acute bronchospasm, 
musculoskeletal injury, narcosis, anxiety, hyperventilation syndrome, solvent inhalation exposure, carbon monoxide 
poisoning, pulmonary embolus, and esophagitis.
(b) Although the patient’s work is mainly supervisory, he may do other work intermittently (e.g., as a replacement 
mechanic). It is important to know not only his job classification, but also his specific duties and what occurs in his 
immediate work environment. Occupational exposures might include solvents, motor fuels, antifreezes, hazardous 
noise, paints, welding fumes, freon, carbon monoxide, and ultraviolet exposure from arc welding. Suboptimal 
ergonomic work stations with heavy lifting or repetitive work could contribute to symptoms. Environmental 
exposures of concern might include solvents, paints, welding fumes, and carbon monoxide from auto repair and 
inadequately vented heating units. Living near industries or hazardous waste sites that release these materials into the 
environment may also result in exposure.
(c) The temporal association of symptoms and use of the degreasing solution suggests a causal relationship. More 
information about the degreaser is needed, including its identity, ingredients, and potential health effects. The identity 
could be obtained from the patient or by checking with the bioenvironmental engineering officer responsible for the
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auto repair shop. The health effects can be determined by talking with the manufacturer, talking with a 
toxicologist at a regional poison control center, or by consulting printed or electronic information sources. If 
the degreaser is not the most likely cause of the patient’s symptoms, other etiologies must be considered. The 
patient should be evaluated to exclude each of the diagnoses in answer (a).
Educating the patient about engineering controls, personal protective measures, and the health effects of Stoddard 
solvent should help prevent future problems. Although the chest tightness may have been triggered by exposure to 
Stoddard or another solvent, the presence of an underlying condition requires further evaluation. Because of the 
patient’s family history, he should be evaluated for etiologies of chest pain, including coronary artery disease or a 
dysrhythmia.
Challenge
(1) It is important to assess whether the children come in contact with the material and, if so, what approximate 
doses they receive. If the material is applied in a well-ventilated area (e.g., outdoors) and in small quantities for a 
limited time, most people would not suffer significant health effects. However, the younger son, who is asthmatic, 
could be at increased risk because the solvent may act as a nonspecific stimulus to provoke bronchoconstriction.
Flammable organic solvents such as Stoddard solvent should be used only by adults, with appropriate ventilation 
and skin protection. All potentially toxic substances should be kept in nonbreakable, clearly labeled containers, 
which should be tightly covered when not in use, and kept out of children’s reach.
(2) Eye and throat irritation suggest that the patient may have been exposed to moderately high levels of Stoddard 
solvent, which could have also caused his CNS complaints (e.g., dizziness and euphoria) and respiratory complaints 
(e.g., burning sensation in the nose and throat). The overexposure could have occurred from widely applying the 
degreaser and heating it in an enclosed space with no ventilation.
Exposure to Stoddard solvent does not result in cardiovascular effects and is unlikely to be the cause of the patient’s 
chest discomfort. The chest discomfort and dizziness are consistent with angina due to underlying cardiac disease or 
a transient dysrhythmia.
(3) The patient most likely has eczematous irritant contact dermatitis (see Case Studies in Environmental 
Medicine: Skin Lesions and Environmental Exposures). Exposure to Stoddard solvent, oils, other irritants, or 
allergens such as metal contaminants should be assessed, and cessation of exposure is recommended. The patient 
should be encouraged to use appropriate skin protection and to avoid contact when possible.
(4) There is no specific laboratory test that would prove the neighbor’s complaints are due to Stoddard solvent. An 
industrial hygiene assessment using personal sampling could be carried out to determine whether the neighbor is 
exposed to Stoddard solvent. Neurobehavioral tests, which are functional tests of the CNS, could indicate whether 
impairment of function has occurred, but they would not indicate etiology.
(5) Advise against further unprotected exposure to known CNS toxicants such as ethanol, solvents, and certain 
gases (e.g., carbon monoxide).
(6) See Pretest answer (c).
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Additional Sources of Information
More information on the adverse effects of Stoddard solvent and on treating cases of Stoddard solvent exposure 
can be obtained from the Agency for Toxic Substances and Disease Registry (ATSDR), your state and local health 
departments, and university medical centers. Case Studies in Environmental Medicine: Stoddard Solvent 
Toxicity is one of a series. To obtain other publications in this series, please use the order form on page 26.
For clinical inquiries, contact ATSDR, Division of Health Education and Promotion, Office of the Director, at 
404-498-0101.
Notes
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Case Studies in Environmental Medicine:
Stoddard Solvent Toxicity
Evaluation Questionnaire and Posttest, Course Number SS3057
Course Goal: To increase the primary care provider’s knowledge of hazardous substances in the environment and 
to aid in evaluating potentially exposed patients.
Objectives
♦ Discuss the major exposure route for Stoddard solvent.
♦ Describe two potential environmental and occupational sources of Stoddard solvent exposure.
♦ State two reasons why Stoddard solvent is a health hazard.
♦ Describe three factors that contribute to Stoddard solvent toxicity.
♦ Identify evaluation and treatment protocols for persons exposed to Stoddard solvent.
♦ List two sources of information on Stoddard solvent.
Tell Us About Yourself
Please carefully read the questions. Provide answers on the answer sheet (page 25). Your credit will be 
awarded based on the type of credit you select.
1. What type of continuing education credit do you wish to receive?
**Nurses should request CNE. not CEU. See note on page 24.
A. CME (for physicians)
B. CME( for non-attending)
C. CNE (continuing nursing education)
D. CEU (continuing education units)
E. AAFP (American Academy of Family Physicians)
F. ACEP (American College of Emergency Physicians)
G AO A (American Osteopathic Association)
H. None of the above
2. Are you a...
A. Nurse
B. Pharmacist
C. Physician
D. Veterinarian
E. None of the above
3. What is your highest level of education?
A. High school or equivalent
B. Associate, 2-year degree
C. Bachelor’s degree
D. Master’s degree
E. Doctorate
F. Other
19
Stoddard Solvent Toxicity
4. Each year, approximately how many patients with Stoddard solvent exposure do you see?
A. None
B. 1-5
C. 6-10
D. 11-15
E. More than 15
5. Which of the following best describes your current occupation?
A. Environmental Health Professional
B. Epidemiologist
C. Health Educator
D. Laboratorian
E. Physician Assistant
F. Industrial Hygienist 
G Sanitarian
H. Toxicologist
I. Other patient care provider 
J. Student
K. None of the above
6. Which of the following best describes your current work setting?
A. Academic (public and private)
B. Private health care organization
C. Public health organization
D. Environmental health organization
E. Non-profit organization
F. Other work setting
7. Which of the following best describes the organization in which you work?
A. Federal government
B. State government
C. County government
D. Local government
E. Non-governmental agency
F. Other type of organization
Tell Us About the Course
8. How did you obtain this course?
A. Downloaded or printed from Web site
B. Shared materials with colleague(s)
C. By mail from ATSDR
D. Not applicable
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9. How did you first learn about this course?
A. State publication (or other state-sponsored communication)
B. MMWR
C. ATSDR Internet site or homepage
D. PHTN source (PHTN Web site, e-mail announcement)
E. Colleague
F. Other
10. What was the most important factor in your decision to obtain this course?
A. Content
B. Continuing education credit
C. Supervisor recommended
D. Previous participation in ATSDR training
E. Previous participation in CDC and PHTN training
F. Ability to take the course at my convenience 
G Other
11. How much time did you spend completing the course, evaluation, and posttest?
A. 1 to 1.5 hours
B. More than 1.5 hours but less than 2 hours
C. 2 to 2.5 hours
D. More than 2.5 hours but less than 3 hours
E. 3 hours or more
12. Please rate your level of knowledge before completing this course.
A. Great deal of knowledge about the content
B. Fair amount of knowledge about the content
C. Limited knowledge about the content
D. No prior knowledge about the content
E. No opinion
13. Please estimate your knowledge gain after completing this course.
A. Gained a great deal of knowledge about the content
B. Gained a fair amount of knowledge about the content
C. Gained a limited amount of knowledge about the content
D. Did not gain any knowledge about the content
E. No opinion
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Please use the scale below to rate your level of agreement with the following statements 
(questions 14-25) about this course.
A. Agree
B. No opinion
C. Disagree
D. Not applicable
14. The objectives are relevant to the goal.
15. The tables and figures are an effective learning resource.
16. The content in this course was appropriate for my training needs.
17. Participation in this course enhanced my professional effectiveness.
18. I will recommend this course to my colleagues.
19. Overall, this course enhanced my ability to understand the content.
20. I am confident I can discuss the major exposure route for Stoddard solvent.
21. I am confident I can describe two potential environmental and occupational sources of Stoddard 
solvent exposure.
22. I am confident I can state two reasons why Stoddard solvent is a health hazard.
23. I am confident I can describe three factors that contribute to Stoddard solvent toxicity.
24. I am confident I can identify evaluation and treatment protocols for persons exposed to Stoddard 
solvent.
25. I am confident I can list two sources of information on Stoddard solvent.
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Posttest
If you wish to receive continuing education credit for this program, you must complete this posttest. Each question 
below contains four suggested answers, of which one or more is correct. Choose the answer:
A if 1, 2, and 3 are correct
B if 1 and 3 are correct
C if 2 and 4 are correct
D if 4 is correct
E if 1, 2, 3, and 4 are correct
26. Acute exposure to Stoddard solvent may adversely affect all of the following except:
(1) CNS
(2) vision and hearing
(3) mucous membranes
(4) pancreas
27. Stoddard solvent would probably be found in which of the following locations?
(1) dry-cleaning plants
(2) print shops
(3) automobile-repair stations
(4) food-processing plants
28. Recommended treatment for acute ingestion of small to moderate amounts of Stoddard solvent 
usually includes which of the following?
( 1 ) steroids and hyperbaric oxygen
(2) gastric lavage
(3) prophylactic antibiotics
(4) symptomatic support
29. Which of the following are associated with exposure to Stoddard solvent?
( 1 ) neurobehavioral changes
(2) dermatitis
(3) visual changes
(4) headaches
30. Consumers may be exposed to Stoddard solvent by which of the following?
(1) paint thinners
(2) chemical cleaning products
(3) dry-cleaned clothes
(4) pesticides
31. Which of the following statement(s) is (are) true?
( 1 ) Stoddard solvent is a superior solvent because it readily dissolves in water
(2) benzene and other aromatic compounds make up approximately 60% of Stoddard solvent
(3) Stoddard solvent is a known developmental toxicant
(4) exposure to Stoddard solvent may cause CNS effects and defatting of the skin
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32. Which of the following tests may be appropriate for monitoring a person chronically exposed to 
Stoddard solvent?
(1) liver function tests
(2) urinalysis
(3) complete blood count
(4) serum amylase
33. Which of the following statement(s) is (are) true?
(1) persons with increased susceptibility to Stoddard solvent toxicity include those with COPD
(2) pulmonary aspiration can be a hazard after Stoddard solvent ingestion
(3) Stoddard solvent can cause CNS toxicity
(4) significant health effects have occurred as a result of drinking Stoddard solvent -contaminated water 
because it is a human carcinogen
Note to Nurses
CDC is accredited by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation. 
ANCC credit is accepted by most State Boards of Nursing.
California nurses should write in “ANCC - Self-Study” for this course when applying for relicensure. A provider 
number is not needed.
Iowa nurses must be granted special approval from the Iowa Board of Nursing. Call 515-281 -4823 or e-mail 
marmago@bon.state.ia.us to obtain the necessary application.
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Answer Sheet, Course Number SS3057
Instructions: Circle your answers. To receive your certificate, you must answer all questions. Mail or fax your 
completed answer sheet to
Continuing Education Coordinator Fax: 404-498-0061
Agency for Toxic Substances and Disease Registry ATTN: Continuing Education Coordinator
Division of Health Education and Promotion, E-33
1600 Clifton Road, NE
Atlanta, GA 30333
If you score 70% or better on the posttest, you will receive an award certificate within 90 days of submitting your 
credit forms. Be sure to fill in your name and address on the back of this form.
Case Studies in Environmental Medicine:
1. A B C D E F G H 18. A B C D
2. A B C D E 19. A B C D
3. A B C D E F 20. A B C D
4. A B C D E 21. A B C D
5. A B C D E F G H I J K 22. A B C D
6. A B C D E F 23. A B C D
7. A B C D E F 24. A B C D
8. A B C D 25. A B C D
9. A B C D E F 26. A B C D E
10. A B C D E F G 27. A B C D E
11. A B C D E 28. A B C D E
12. A B C D E 29. A B C D E
13. A B C D E 30. A B C D E
14 A B C D 31. A B C D E
15. A B C D 32. A B C D E
16. A B C D 33. A B C D E
17. A B C D
Name: E-mail (not required):
Address:
□  Check here 
to be placed 
on the 
mailing list
Zip Code:
Remember, you can access the case studies online at 
www.atsdr.cdc.aov/HEC/CSEM/ and complete the evaluation 
questionnaire and posttest online at www.phppo.cdc.qov/phtnonline.
Online access allows you to receive your certificate as soon as you 
successfully pass the posttest (score 70% or better).
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Continuing Education Coordinator 
Agency for Toxic Substances and Disease Registry 
Division of Health Education and Promotion, E-33 
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